Fox Jonathan C 4
4 · Edgewise Therapeutics, Inc. · Filed Jun 12, 2024
Insider Transaction Report
Form 4
Fox Jonathan C
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-10+20,594→ 20,594 totalExercise: $17.13From: 2025-06-10Exp: 2034-06-10→ Common Stock (20,594 underlying)
Footnotes (1)
- [F1]100% of the Stock Options granted on June 10, 2024 will become vested on the earlier of (i) June 10, 2025 or (ii) the business day prior to the 2025 annual meeting of stockholders.